IP Library Granted Patent US 7,211,251
Granted Patent B2
US 7,211,251 · App. 11/448,552 · Granted May 1, 2007

Antibodies to transferrin receptor-like proteins

Assignee: Cedars-Sinai Medical Center
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,211,251
App. No.
11/448,552
Granted
May 1, 2007
Kind
B2
Abstract

The present invention provides isolated nucleic acids encoding TfR2 polypeptides, or fragments thereof, and isolated TfR2 polypeptides encoded thereby. Further provided are vectors containing the nucleic acids of the present invention, host cells transformed therewith, antisense oligonucleotides thereto and compositions containing antibodies that specifically bind to invention polypeptides. Methods of detecting TfR2 protein in a cell are also provided.

Claims (4)

1. An isolated antibody that specifically binds to the TfR2 polypeptide of SEQ ID NO: 1.

2. The antibody of claim 1 , wherein the antibody is a monoclonal antibody.

3. The antibody of claim 1 , wherein the antibody is a polyclonal antibody.

4. A composition comprising the antibody of claim 1 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 13, 2016
From: CEDARS-SINAI MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039323/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2006
From: KAWABATA, HIROSHI; KOEFFLER, H. PHILIP
To: CEDARS-SINAI MEDICAL CENTER
Reel/Frame 017983/0618 →
Continuity (4)
Division 1100595700 · Dec 7, 2004
Division 0935875500 · Jul 22, 1999
Provisional Application 6010750200 · Nov 6, 1998
Related Publication 20060216758A1 · Sep 28, 2006